Literature DB >> 16631427

A functional polymorphism in MMP-9 is associated with childhood atopic asthma.

Kazuko Nakashima1, Tomomitsu Hirota, Kazuhiko Obara, Makiko Shimizu, Satoru Doi, Kimie Fujita, Taro Shirakawa, Tadao Enomoto, Shigemi Yoshihara, Motohiro Ebisawa, Kenji Matsumoto, Hirohisa Saito, Yoichi Suzuki, Yusuke Nakamura, Mayumi Tamari.   

Abstract

Although MMP-9 has been suggested to be important in inflammation and in the connective tissue remodeling associated with asthma, the genetic influences of the polymorphisms of MMP-9 are unclear. To examine whether polymorphisms in MMP-9 are associated with childhood atopic asthma, we identified a total of 17 polymorphisms and conducted an association study with asthma (n = 290) and controls (n = 638). 2127G>T and 5546G>A (R668Q) were significantly associated with the risk of childhood atopic asthma (p = 0.0032 and 0.0016, respectively). In haplotype analysis, we also found a positive association with a haplotype (p = 0.0053). MMP-9 was expressed in cultured human bronchial epithelial cells, and the mRNA expression level was upregulated by dsRNA. Furthermore, the promoter SNP -1590C>T, in strong linkage disequilibrium with 2127G>T, enhanced the transcriptional level of MMP-9. Thus, the MMP-9 gene might be involved in the development of asthma through functional genetic polymorphisms.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16631427     DOI: 10.1016/j.bbrc.2006.03.102

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  8 in total

Review 1.  DNA sequence variations of metalloproteinases: their role in asthma and COPD.

Authors:  Fotis Sampsonas; Alexander Kaparianos; Dimosthenis Lykouras; Kiriakos Karkoulias; Kostas Spiropoulos
Journal:  Postgrad Med J       Date:  2007-04       Impact factor: 2.401

2.  Strain and model dependent differences in inflammatory cell recruitment in mice.

Authors:  J L Hoover-Plow; Y Gong; A Shchurin; S J Busuttil; T A Schneeman; E Hart
Journal:  Inflamm Res       Date:  2008-10       Impact factor: 4.575

3.  Induction of the Matrix Metalloproteinase 13 Gene in Bronchial Epithelial Cells by Interferon and Identification of its Novel Functional Polymorphism.

Authors:  Yoichi Mashimo; Mika Sakurai-Yageta; Misa Watanabe; Takayasu Arima; Yoshinori Morita; Yuzaburo Inoue; Kazuki Sato; Toshiyuki Nishimuta; Shuichi Suzuki; Hiroko Watanabe; Akira Hoshioka; Minako Tomiita; Akiko Yamaide; Yoichi Kohno; Yoshitaka Okamoto; Naoki Shimojo; Akira Hata; Yoichi Suzuki
Journal:  Inflammation       Date:  2016-06       Impact factor: 4.092

4.  MMP9 polymorphism is associated with susceptibility to non-traumatic osteonecrosis of femoral head in a Chinese Han population.

Authors:  Yuan Liu; Yanfei Jia; Yuju Cao; Yan Zhao; Jieli Du; Feimeng An; Yuxin Qi; Xue Feng; Tianbo Jin; Jianping Shi; Jianzhong Wang
Journal:  Oncotarget       Date:  2017-08-24

5.  A single-nucleotide polymorphism in MMP9 is associated with decreased risk of steroid-induced osteonecrosis of the femoral head.

Authors:  Jieli Du; Wanlin Liu; Tianbo Jin; Zhenqun Zhao; Rui Bai; Huiqin Xue; Junyu Chen; Mingqi Sun; Xiyang Zhang; Guoqiang Wang; Jianzhong Wang
Journal:  Oncotarget       Date:  2016-10-18

Review 6.  Association of Matrix Metalloproteinase 9 (MMP-9) Polymorphisms with Asthma Risk: A Meta-Analysis.

Authors:  Fenfang Zou; Jianpeng Zhang; Guoan Xiang; Hongbin Jiao; Hongmei Gao
Journal:  Can Respir J       Date:  2019-02-25       Impact factor: 2.409

7.  Identification of an Alveolar Macrophage-Related Core Gene Set in Acute Respiratory Distress Syndrome.

Authors:  Chunling Zhao; Jingjia Mo; Xiaowen Zheng; Zimeng Wu; Qian Li; Jihua Feng; Jiefeng Luo; Junyu Lu; Jianfeng Zhang
Journal:  J Inflamm Res       Date:  2021-06-01

8.  Significant Association of MMP2 Promoter Genotypes to Asthma Susceptibility in Taiwan.

Authors:  Li-Hsiou Chen; Kuo-Liang Chiu; Te-Chun Hsia; Yen-Hsien Lee; Te-Chun Shen; Chia-Hsiang Li; Yi-Cheng Shen; Wen-Shin Chang; Chia-Wen Tsai; DA-Tian Bau
Journal:  In Vivo       Date:  2020 Nov-Dec       Impact factor: 2.155

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.